Arun Krishna

Arun Krishna

Articles by Arun Krishna

Arun Krishna on the FLAURA2 Trial Results: Tagrisso Effectively Combats NSCLC

Arun KrishnaNon-Small Cell Lung Cancer | April 4, 2024

Arun Krishna, of AstraZeneca, talks about the phase 3 FLAURA2 trial, which assessed Tagrisso in patients with NSCLC.

Arun Krishna, AstraZeneca: Tagrisso Proven Effective at Treating NSCLC

Arun KrishnaNon-Small Cell Lung Cancer | November 9, 2023

Arun Krishna, of AstraZeneca, spoke about the FLAURA2 trial, which showed the efficacy of Tagrisso in the treatment of NSCLC.